Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,906 | 107 | 94.3% |
| Consulting Fee | $100.00 | 1 | 4.9% |
| Education | $14.63 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $291.22 | 22 | $0 (2021) |
| PFIZER INC. | $213.88 | 17 | $0 (2019) |
| Janssen Biotech, Inc. | $210.59 | 11 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $134.83 | 7 | $0 (2023) |
| ABBVIE INC. | $121.21 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $102.64 | 6 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $101.73 | 2 | $0 (2021) |
| Olympus America Inc. | $100.79 | 1 | $0 (2018) |
| COMSORT, Inc | $100.00 | 1 | $0 (2019) |
| Amgen Inc. | $79.45 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $182.77 | 9 | Bayer Healthcare Pharmaceuticals Inc. ($39.38) |
| 2023 | $186.47 | 10 | Bayer Healthcare Pharmaceuticals Inc. ($63.26) |
| 2021 | $227.66 | 8 | TOLMAR Pharmaceuticals, Inc. ($87.37) |
| 2020 | $195.40 | 11 | AbbVie Inc. ($43.33) |
| 2019 | $431.18 | 20 | COMSORT, Inc ($100.00) |
| 2018 | $440.21 | 20 | Olympus America Inc. ($100.79) |
| 2017 | $356.69 | 31 | PFIZER INC. ($141.97) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Oncology | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Oncology | ||||||
| 08/08/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 04/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: UROLOGY | ||||||
| 04/16/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 03/28/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: AMS 700_URO | ||||||
| 02/29/2024 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: UROLOGY | ||||||
| 02/26/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Oncology | ||||||
| 08/28/2023 | Foundation Medicine, Inc. | FOUNDATIONONE CDX (Device) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Oncology | ||||||
| 08/11/2023 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Oncology | ||||||
| 08/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Oncology | ||||||
| 06/28/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/13/2023 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Oncology | ||||||
| 05/24/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Oncology | ||||||
| 04/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Oncology | ||||||
| 04/06/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: ONCOLOGY | ||||||
| 02/15/2023 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Oncology | ||||||
| 01/25/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Urology | ||||||
| 10/12/2021 | Photocure Inc | Cysview (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Oncology | ||||||
| 07/13/2021 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/23/2021 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Interventional Urology | ||||||
| 06/16/2021 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $87.37 | General |
| Category: Prostate Cancer | ||||||
| 03/22/2021 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Bone Health | ||||||
| 03/11/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 690 | 754 | $142,178 | $34,105 |
| 2021 | 16 | 1,006 | 1,177 | $292,305 | $77,305 |
| 2020 | 27 | 2,193 | 6,647 | $686,280 | $228,877 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 212 | 239 | $63,574 | $15,198 | 23.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 75 | 75 | $19,575 | $6,002 | 30.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 77 | 83 | $10,956 | $3,585 | 32.7% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 69 | 72 | $19,080 | $3,114 | 16.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 23 | $6,923 | $2,069 | 29.9% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 18 | 18 | $7,398 | $1,372 | 18.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 109 | 126 | $7,686 | $1,063 | 13.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 11 | 11 | $4,631 | $833.35 | 18.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 12 | 13 | $1,885 | $664.95 | 35.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 84 | 94 | $470.00 | $204.60 | 43.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 25 | 150 | $63,750 | $26,282 | 41.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 314 | 331 | $85,295 | $18,987 | 22.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 206 | 225 | $54,369 | $16,436 | 30.2% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 56 | 58 | $25,230 | $3,258 | 12.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 30 | 30 | $10,215 | $2,731 | 26.7% |
| 76856 | Ultrasound of pelvis, complete, not pregnancy related | Office | 2021 | 25 | 25 | $9,358 | $2,106 | 22.5% |
| 76770 | Ultrasound behind abdominal cavity | Office | 2021 | 24 | 24 | $8,744 | $2,095 | 24.0% |
| 76775 | Ultrasound behind abdominal cavity, limited | Office | 2021 | 35 | 35 | $9,275 | $1,348 | 14.5% |
| 55700 | Biopsy of prostate gland | Facility | 2021 | 12 | 12 | $6,900 | $1,107 | 16.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 130 | 133 | $8,050 | $942.09 | 11.7% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2021 | 27 | 28 | $3,920 | $636.18 | 16.2% |
| 51702 | Insertion of indwelling bladder catheter, simple | Office | 2021 | 11 | 11 | $1,595 | $431.56 | 27.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 13 | $1,248 | $412.41 | 33.0% |
| 76872 | Ultrasound of pelvic region through rectum | Facility | 2021 | 12 | 12 | $3,900 | $327.60 | 8.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 74 | 78 | $390.00 | $171.00 | 43.8% |
About Dr. Harold Genvert, MD
Dr. Harold Genvert, MD is a Urology healthcare provider based in Salisbury, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891756748.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harold Genvert, MD has received a total of $2,020 in payments from pharmaceutical and medical device companies, with $182.77 received in 2024. These payments were reported across 109 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($1,906).
As a Medicare-enrolled provider, Genvert has provided services to 3,889 Medicare beneficiaries, totaling 8,578 services with total Medicare billing of $340,287. Data is available for 3 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Salisbury, MD
- Active Since 03/30/2006
- Last Updated 03/12/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1891756748
Products in Payments
- XTANDI (Drug) $198.11
- KEYTRUDA (Biological) $137.74
- PROVENGE (Drug) $134.83
- VIAGRA (Drug) $127.97
- ELIGARD (Drug) $101.73
- Olympus Cysto-Resection (Device) $100.79
- Myrbetriq (Drug) $92.29
- Prolia (Biological) $79.45
- Erleada (Drug) $78.99
- LUPRON DEPOT (Drug) $78.82
- ZYTIGA (Drug) $78.81
- TOVIAZ (Drug) $71.28
- Nubeqa (Drug) $67.00
- ERLEADA (Drug) $52.79
- BOTOX THERAPEUTIC (Biological) $44.82
- GEMTESA (Drug) $44.61
- CAMCEVI (Drug) $43.39
- GentleCath (Device) $39.53
- FIRMAGON (Drug) $39.02
- PYLARIFY (Drug) $38.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Salisbury
Dr. Alyssa Gracely, M.d, M.D
Urology — Payments: $22,409
Dr. Mark Shimko, Md, MD
Urology — Payments: $5,623
Jason Greenlee, D.o, D.O
Urology — Payments: $5,442
Robert Bertram, Md, MD
Urology — Payments: $2,874
Atlee Johnson, Md, MD
Urology — Payments: $2,801
Dr. Wayne Cline, Md, MD
Urology — Payments: $1,728